Data / Drug companies / Acs Dobfar S.p.A
Acs Dobfar S.p.A: 37 products in the FDA NDC directory, labeler code 52946
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Acs Dobfar S.p.A (labeler code 52946) lists 37 products in the FDA National Drug Code Directory. By type: 35 bulk ingredients, 2 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on January 1, 2025.
The request: Watch Acs Dobfar S.p.A (FDA labeler code 52946): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52946
- Products in commercial distribution
- 37
- Packages
- 37
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- December 9, 2009
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 35 | 94.6% |
| Drugs for further processing | 2 | 5.4% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 35 | 94.6% |
| Drugs for further processing | 2 | 5.4% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 36 | 97.3% |
| Liquid | 1 | 2.7% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Piperacillin and tazobactam (sterile) | 52946-0927 | Powder | Bulk ingredients | January 1, 2025 |
| Imipenem | 52946-0930 | Powder | Bulk ingredients | October 18, 2022 |
| Cilastatin sodium | 52946-0928 | Powder | Bulk ingredients | October 7, 2022 |
| Cefepime hcl crude | 52946-0926 | Powder | Bulk ingredients | September 1, 2022 |
| Tazobactam sodium sterile | 52946-0925 | Powder | Bulk ingredients | June 18, 2020 |
| Ceftazidime | 52946-0924 | Powder | Bulk ingredients | May 22, 2019 |
| Ceftolozane drug product intermediate | 52946-0923 | Powder | Bulk ingredients | September 14, 2015 |
| Ceftriaxone sodium non sterile | 52946-0920 | Powder | Bulk ingredients | June 13, 2013 |
| Nafcillin sodium | 52946-0922 | Powder | Bulk ingredients | August 30, 2012 |
| Gentamicin sulate | 52946-0605 | Powder | Bulk ingredients | April 19, 2010 |
| Cefepime | 52946-0919 | Powder | Bulk ingredients | March 2, 2010 |
| Cefotetan disodium | 52946-0834 | Powder | Bulk ingredients | December 10, 2009 |
| Cefaclor monohydrate | 52946-0912 | Powder | Bulk ingredients | December 9, 2009 |
| Cephalexin monohydrate | 52946-0906 | Powder | Bulk ingredients | December 9, 2009 |
| Cefuroxime sodium | 52946-0905 | Powder | Bulk ingredients | December 9, 2009 |
| Cefadroxil monohydrate | 52946-0903 | Powder | Bulk ingredients | December 9, 2009 |
| Ampicillin sodium | 52946-0901 | Powder | Bulk ingredients | December 9, 2009 |
| Meropenem | 52946-0839 | Powder | Bulk ingredients | December 9, 2009 |
| Imipenem and cilastatin | 52946-0838 | Powder | Drugs for further processing | December 9, 2009 |
| Cefepime hydrochloride oral grade | 52946-0837 | Powder | Bulk ingredients | December 9, 2009 |
| Cefoxitin sodium | 52946-0828 | Powder | Bulk ingredients | December 9, 2009 |
| Ceftriaxone sodium sterile bulk | 52946-0827 | Powder | Bulk ingredients | December 9, 2009 |
| Cefotaxime sodium | 52946-0826 | Powder | Bulk ingredients | December 9, 2009 |
| Nafcillin sodium | 52946-0819 | Powder | Bulk ingredients | December 9, 2009 |
| Cloxacillin benzathine | 52946-0816 | Powder | Bulk ingredients | December 9, 2009 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.